SUZANNE FUQUA to Protein Kinase Inhibitors
This is a "connection" page, showing publications SUZANNE FUQUA has written about Protein Kinase Inhibitors.
Connection Strength
0.438
-
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells. Mol Cancer Ther. 2006 Dec; 5(12):3023-31.
Score: 0.177
-
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Br J Cancer. 2021 01; 124(1):191-206.
Score: 0.117
-
ESR1 mutations in breast cancer. Cancer. 2019 11 01; 125(21):3714-3728.
Score: 0.106
-
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer. Mol Cancer Ther. 2024 Oct 01; 23(10):1494-1510.
Score: 0.038